PPARγ-targeting Potential for Radioprotection
- PMID: 29384061
- DOI: 10.2174/1389450119666180131105158
PPARγ-targeting Potential for Radioprotection
Abstract
Background: Peroxisomal proliferator receptor gamma (PPARγ) is a class of nuclear hormone receptor family involved in insulin sensitization. In addition, PPARγ has a key role in the protection against oxidative stress and inflammation through regulation of NFkappaB levels and crosstalk with the Nrf2 pathway. Also, its role in the modulation of immune response is substantial.
Objective: Radiation-induced oxidative stress is the sole determinant of damage to hematopoietic, gastrointestinal system and immune system suppression. Uncontrolled exposure to normal cells during radiotherapy raises the demand for novel and efficient radioprotectors. In this review, we will present an overview of the involvement of PPARγ in radiation-induced damage and inflammation with major emphasis on whether PPARγ can serve as a suitable radiomodification target.
Conclusion: Through this review, we have justified that PPARγ having both radioprotective as wells as radiotherapeutic potential, may serve as an attractive target for the development of novel and more effective therapies.
Keywords: NFkappaB; PPARγ; cancer; inflammationnitrosylation; oxidative stress; radiation..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.Chem Biol Interact. 2017 Nov 1;277:146-158. doi: 10.1016/j.cbi.2017.09.015. Epub 2017 Sep 19. Chem Biol Interact. 2017. PMID: 28935427
-
Monascin and AITC attenuate methylglyoxal-induced PPARγ phosphorylation and degradation through inhibition of the oxidative stress/PKC pathway depending on Nrf2 activation.J Agric Food Chem. 2013 Jun 26;61(25):5996-6006. doi: 10.1021/jf401197r. Epub 2013 Jun 13. J Agric Food Chem. 2013. PMID: 23731245
-
Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.Front Immunol. 2018 Apr 13;9:745. doi: 10.3389/fimmu.2018.00745. eCollection 2018. Front Immunol. 2018. PMID: 29706964 Free PMC article. Review.
-
Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.Free Radic Biol Med. 2012 Dec 1;53(11):2008-16. doi: 10.1016/j.freeradbiomed.2012.09.025. Epub 2012 Sep 26. Free Radic Biol Med. 2012. PMID: 23022408
-
Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury.Oxid Med Cell Longev. 2017;2017:1378175. doi: 10.1155/2017/1378175. Epub 2017 Aug 27. Oxid Med Cell Longev. 2017. PMID: 28928902 Free PMC article. Review.
Cited by
-
Mitigation of radiation mediated testicular dysfunction by α-tocopheryl succinate: PPAR-γ related pathway.BMC Complement Med Ther. 2025 Jun 9;25(1):211. doi: 10.1186/s12906-025-04950-7. BMC Complement Med Ther. 2025. PMID: 40490803 Free PMC article.
-
NS3 of hepatitis C virus drives hepatocellular carcinoma progression through a novel RNA-interference pathway.J Cell Commun Signal. 2025 Apr 12;19(2):e70013. doi: 10.1002/ccs3.70013. eCollection 2025 Jun. J Cell Commun Signal. 2025. PMID: 40226576 Free PMC article.
-
The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis.Ann Transl Med. 2021 Apr;9(8):684. doi: 10.21037/atm-21-1070. Ann Transl Med. 2021. PMID: 33987382 Free PMC article.
-
Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases.Chin Med. 2020 Aug 26;15:89. doi: 10.1186/s13020-020-00371-5. eCollection 2020. Chin Med. 2020. PMID: 32863858 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical